Top compounds associated with response to RP11-96L14.7


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.07 0.03
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.24 0.03
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.078 0.03
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.069 0.03
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.04
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA thalidomide CTRPv2 pan-cancer AAC -0.11 0.04
Download CSV